Identity
- Security key
- 21080
- Ticker
- RNXT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-08-26
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- RNXT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $50,511,028.96
- Shares outstanding (class)
- 45,052,706
- Shares outstanding (weighted)
- 45,099,133
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 17
- Location
- MOUNTAIN VIEW, CA
- Homepage
- https://www.renovorx.com
- Description
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.